Tracking TVRD historical volatility helps you see how much Tvardi Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Tvardi Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor TVRD 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The TVRD 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Tvardi Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Tvardi Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where TVRD HV is running hot, cold, or in line. Make the TVRD 30 day historical volatility — and every other window — work for your edge instead of against it.
